Octreotide Acetate

Known as: Octreotide Acetate Salt, D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hyroxymethyl)propyl]-L-cysteinamide, Cyclic (2->7)-disulfide, Acetate (Salt), SMS 201-995 AC 
The acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
OBJECTIVES Octreotide long acting repeatable (LAR) is widely used for the control of symptoms of functional neuroendocrine tumors… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
HYPOTHESIS Prophylactic administration of octreotide acetate decreases the rate of postoperative intra-abdominal complications… (More)
Is this relevant?
2003
2003
BACKGROUND Somatostatin analogues are the best therapy for controlling the symptoms of malignant carcinoid syndrome. Octreotide… (More)
Is this relevant?
2000
2000
BACKGROUND In the present study we investigated the efficacy and tolerability of i.m. octreotide acetate (octreotide LAR) in… (More)
  • table 1
  • figure 1
Is this relevant?
2000
2000
BACKGROUND AND OBJECTIVE The most effective option for the medical treatment of patients with acromegaly is the use of… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE Subcutaneous (SC) octreotide acetate effectively relieves the diarrhea and flushing associated with carcinoid syndrome… (More)
Is this relevant?
1996
1996
Double-blind, single-dose studies of 120 acromegalic patients given 10, 20, and 30 mg Sandostatin LAR (Sandoz Pharma Ltd, Basel… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
One hundred and three acromegalic patients from 14 medical centers were enrolled in this study to determine the efficacy and… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
OBJECTIVE To determine the effects of the somatostatin analog, octreotide acetate, in patients with acromegaly. DESIGN Double… (More)
Is this relevant?
1989
1989
Somatostatin and its analogs have been shown to inhibit both pancreatic endocrine and exocrine function. We hypothesized that… (More)
Is this relevant?